Search Results - "McCreary, Erin"

Our "Side Hustle" by McCreary, Erin K

Get full text

Efficacy of Remdesivir in COVID-19 by McCreary, Erin K, Angus, Derek C

Get full text

Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options by McCreary, Erin K, Pogue, Jason M

“…Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), has spread across the globe resulting…”
Get full text

New Perspectives on Antimicrobial Agents: Cefiderocol by McCreary, Erin K, Heil, Emily L, Tamma, Pranita D

“…Bacterial resistance to carbapenem agents has reached alarming levels. Accordingly, collaborative efforts between national and international organizations and…”
Get full text

Healthcare practitioners' views of social media as an educational resource by Pizzuti, Adam G, Patel, Karan H, McCreary, Erin K, Heil, Emily, Bland, Christopher M, Chinaeke, Eric, Love, Bryan L, Bookstaver, P Brandon

“…Social media is increasingly utilized as a resource in healthcare. We sought to identify perceptions of using social media as an educational tool among…”
Get full text

Covid-19 controversies: the tocilizumab chapter by McCreary, Erin K, Meyer, Nuala J

Get more information

Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic by Seymour, Christopher W, McCreary, Erin K, Stegenga, Jacob

Get full text

Less Is More? Antibiotic Treatment Duration in Pseudomonas aeruginosa Ventilator-Associated Pneumonia by Albin, Owen R, Kaye, Keith S, McCreary, Erin K, Pogue, Jason M

“…Recommended antimicrobial treatment durations for ventilator-associated pneumonia (VAP) caused by Pseudomonas aeruginosa have evolved over the past few…”
Get full text

Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists: Endorsed by the Mycoses Study Group Education and Research Consortium by McCreary, Erin K, Davis, Matthew R, Narayanan, Navaneeth, Andes, David R, Cattaneo, Dario, Christian, Robbie, Lewis, Russell E, Watt, Kevin M, Wiederhold, Nathan P, Johnson, Melissa D

“…Triazole antifungals (i.e., fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole) are commonly used in clinical practice to prevent or…”
Get full text

Early Experience With Meropenem-Vaborbactam for Treatment of Carbapenem-resistant Enterobacteriaceae Infections by Shields, Ryan K, McCreary, Erin K, Marini, Rachel V, Kline, Ellen G, Jones, Chelsea E, Hao, Binghua, Chen, Liang, Kreiswirth, Barry N, Doi, Yohei, Clancy, Cornelius J, Nguyen, M Hong

“…Abstract Twenty patients with carbapenem-resistant Enterobacteriaceae infections were treated with meropenem-vaborbactam. Thirty-day clinical success and…”
Get full text

Acute Kidney Injury With Empirical Antibiotics for Sepsis by Tong, Steven Y. C, Venkatesh, Balasubramanian, McCreary, Erin K

Get full text

Remdesivir: a pendulum in a pandemic by Schwartz, Ilan S, Heil, Emily L, McCreary, Erin K

Get more information

Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments by McCreary, Erin K, Kullar, Ravina, Geriak, Matthew, Zasowski, Evan J, Rizvi, Khulood, Schulz, Lucas T, Ouellette, Krista, Vasina, Logan, Haddad, Fadi, Rybak, Michael J, Zervos, Marcus J, Sakoulas, George, Rose, Warren E

“…Daptomycin and ceftaroline (DAP-CPT) have been used for persistent methicillin-resistant bacteremia (MRSAB), but have rarely been compared with other…”
Get full text

Monoclonals for patients hospitalised with COVID-19 by Pogue, Jason M, McCreary, Erin K

Get full text

Isavuconazole is as effective as and better tolerated than voriconazole for antifungal prophylaxis in lung transplant recipients by Samanta, Palash, Clancy, Cornelius J, Marini, Rachel V, Rivosecchi, Ryan M, McCreary, Erin K, Shields, Ryan K, Falcione, Bonnie A, Viehman, Alex, Sacha, Lauren, Kwak, Eun Jeong, Silveira, Fernanda P, Sanchez, Pablo G, Morrell, Matthew, Clarke, Lloyd, Nguyen, M Hong

“…Invasive fungal infections (IFIs) are common following lung transplantation. Isavuconazole is unstudied as prophylaxis in organ transplant recipients. We…”
Get full text

Isavuconazole for treatment of refractory coccidioidal meningitis with concomitant cerebrospinal fluid and plasma therapeutic drug monitoring by Davis, Matthew R, Chang, Sandy, Gaynor, Pryce, McCreary, Erin K, Allyn, Paul

“…Coccidioidal meningitis (CM) is a life-threatening infection with limited treatment options. Small series have reported success with isavuconazole; however,…”
Get full text

Antibiotic Myths for the Infectious Diseases Clinician by McCreary, Erin K, Johnson, Melissa D, Jones, Travis M, Spires, S Shaefer, Davis, Angelina E, Dyer, April P, Ashley, Elizabeth Dodds, Gallagher, Jason C

“…Abstract Antimicrobials are commonly prescribed and often misunderstood. With more than 50% of hospitalized patients receiving an antimicrobial agent at any…”
Get full text

Tixagevimab Plus Cilgavimab Does Not Affect the Interpretation of Electrophoretic and Free Light Chain Assays by Baloda, Vandana, McCreary, Erin K, Goscicki, Breana K, Shurin, Michael R, Wheeler, Sarah E

“…Abstract Objectives There is concern that the anti–severe acute respiratory syndrome coronavirus 2 therapeutic monoclonal antibodies, used as preexposure…”
Get full text

Which trial do we need? Empiric Glycopeptides plus clindamycin versus Oxazolidinones for suspected toxic shock and necrotizing soft tissue infections by Osowicki, Joshua, Hamilton, Fergus, Lee, Todd C, Marks, Michael, McCreary, Erin K, McDonald, Emily G, Ryder, Jonathan H, Tong, Steven Y C

Get more information

Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19 : A Cohort Study by Kip, Kevin E, McCreary, Erin K, Collins, Kevin, Minnier, Tami E, Snyder, Graham M, Garrard, William, McKibben, Jeffrey C, Yealy, Donald M, Seymour, Christopher W, Huang, David T, Bariola, J Ryan, Schmidhofer, Mark, Wadas, Richard J, Angus, Derek C, Kip, Paula L, Marroquin, Oscar C

“…Treatment guidelines and U.S. Food and Drug Administration emergency use authorizations (EUAs) of monoclonal antibodies (mAbs) for treatment of high-risk…”
Get full text